Oncotarget: Retaining nanomolar potency in lung cancer with therapy-refractory mutations
| Date | 24th, May 2021 |
|---|---|
| Source | EurekAlert - Scientific News Websites |
DESCRIPTION
The gene correlates of LP-184 sensitivity allow additional personalization of therapeutic options for future treatment of NSCLC.